2,282
Views
1
CrossRef citations to date
0
Altmetric
Coronaviruses

Associations between SARS-CoV-2 infection and incidence of new chronic condition diagnoses: a systematic review

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & show all
Article: 2204166 | Received 21 Feb 2023, Accepted 13 Apr 2023, Published online: 01 May 2023

References

  • Haleem A, Javaid M, Vaishya R. Effects of COVID-19 pandemic in daily life. Curr Med Res Pract. 2020;10(2):78–79.
  • Government of Canada. COVID-19 epidemiology update: Key updates Ottawa, Canada. Ottawa: Government of Canada; 2023; [updated 2023-01-16;2023-01-18]. Available from: https://health-infobase.canada.ca/covid-19/#a2.
  • Higgins V, Sohaei D, Diamandis EP, et al. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2021;58(5):297–310.
  • Zimmermann P, Pittet LF, Curtis N. The challenge of studying long COVID: an updated review. Pediatr Infect Dis J. 2022;41(5):424–426.
  • Silva Andrade B, Siqueira S, de A, et al. Hematological profile of pregnant women with suspected Zika virus infection followed up at a referral service in manaus, Brazil. Viruses. 2021;13(4):710.
  • Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob. Health. 2021;6(9):e005427.
  • Banerjee M, Pal R, Dutta S. Risk of incident diabetes post-COVID-19: a systematic review and meta-analysis. Prim Care Diabetes. 2022;16(4):591–593.
  • Veazie S, Lafavor B, Vela K, et al. Mental health outcomes of adults hospitalized for COVID-19: a systematic review. J Affect Disord Rep. 2022 Apr;8:100312.
  • Renaud-Charest O, Lui LMW, Eskander S, et al. Onset and frequency of depression in post-COVID-19 syndrome: a systematic review. J Psychiatr Res. 2021;144:129–137.
  • Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection. JAMA Netw Open. 2021;4(10):e2128568.
  • Yang T, Yan MZ, Li X, et al. Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis. Infection. 2022;50(5):1067–1109.
  • Zeng N, Zhao YM, Yan W, et al. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry. 2023;28(1):423–433.
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89.
  • Barua B, Jacques D. Comparing performance of universal health care countries, 2018. Vancouver: Fraser Institute; 2018.
  • Morrison A, Polisena J, Husereau D, et al. The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care. 2012 Apr;28(2):138–144.
  • Tartof SY, Malden DE, Liu IA, et al. Health care utilization in the 6 months following SARS-CoV-2 infection. JAMA Netw Open. 2022;5(8):e2225657.
  • McGowan J, Sampson M, Salzwedel DM, et al. Press peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40–46.
  • DistillerSR Inc. Ai review Ottawa, Canada: Evidence Partners; 2022 [cited 2023 Jan 19, 2023]. Available from: http://v2dis-help.evidencepartners.com/1/en/topic/ai-preview-and-rank.
  • Burns JK, Etherington C, Cheng-Boivin O, et al. Using an artificial intelligence tool can be as accurate as human assessors in level one screening for a systematic review. Health Info Libr J. 2021;00:1–13.
  • Moola S, Munn Z, Tufanaru C, et al. Chapter 7: systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. Joanna Briggs institute reviewer's manual. Adelaide: The Joanna Briggs Institute; 2017:219–271.
  • Schünemann H, Brożek J, Guyatt G, et al. GRADE Handbook 2013 [cited 2023 Jan 13, 2023]. Available from: https://gdt.gradepro.org/app/handbook/handbook.html.
  • Zeng L, Brignardello-Petersen R, Hultcrantz M, et al. GRADE guidance 34: update on rating imprecision using a minimally contextualized approach. J Clin Epidemiol. 2022;150:216–224.
  • Foroutan F, Guyatt G, Zuk V, et al. GRADE guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks. J Clin Epidemiol. 2020 May;121:62–70.
  • Gates M, Pillay J, Wingert A, et al. Risk factors associated with severe outcomes of COVID-19: a systematic rapid review to inform national guidance on vaccine prioritization in Canada [pre-print]. MedRxiv. 2021 Nov:2021.04.23.21256014.
  • Pillay J, Rahman S, Guitard S, et al. Risk factors and preventive interventions for post COVID-19 condition: systematic review. Emerg Microbes Infect. 2022;11(1):2762–2780.
  • Yek C, Warner S, Wiltz JL, et al. Risk factors for severe COVID-19 outcomes among persons aged >/ = 18 years who completed a primary COVID-19 vaccination series - 465 health care facilities, United States, December 2020-October 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 7;71(1):19–25.
  • Saini G, Aneja R. Cancer as a prospective sequela of long COVID-19. Bioessays. 2021;43(6):2000331.
  • Decker KM, Feely A, Bucher O, et al. Evaluating the impact of the COVID-19 pandemic on cancer screening in a central Canadian province. Prev Med. 2022;155:106961.
  • Halfmann PJ, Iida S, Iwatsuki-Horimoto K, et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature. 2022;603:687–692.
  • Hui KPY, Ho JCW, Cheung MC, et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022;603(7902):715–720.
  • Natekar JP, Pathak H, Stone S, et al. Differential pathogenesis of SARS-CoV-2 variants of concern in human ACE2-expressing mice. Viruses. 2022;14(6):1139.
  • Abel KM, Carr MJ, Ashcroft DM, et al. Association of SARS-CoV-2 infection with psychological distress, psychotropic prescribing, fatigue, and sleep problems among UK primary care patients. JAMA Network Open. 2021;4(11):e2134803.
  • Ayoubkhani D, Khunti K, Nafilyan V, et al. Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ (Clinical Research ed). 2021;372:n693.
  • Bohlken J, Weber K, Riedel Heller  S, et al. Mild cognitive disorder in post-COVID-19 syndrome: a retrospective cohort study of 67,000 primary care post-COVID patients. Journal of Alzheimer's Disease Reports. 2022;6(1):297–305.
  • Chevinsky JR, Tao G, Lavery AM, et al. Late conditions diagnosed 1-4 months following an initial coronavirus disease 2019 (COVID-19) encounter: a matched-cohort study using inpatient and outpatient administrative data-United States, 1 March-30 June 2020. Clin Infect Dis. 2021 Jul 15;73(Suppl 1):S5–S16.
  • Cohen K, Ren S, Heath K, et al. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ (Clinical Research ed). 2022;376:e068414.
  • Daugherty SE, Guo Y, Heath K, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ (Clinical Research ed). 2021;373:n1098.
  • Donnachie E, Hapfelmeier A, Linde K, et al. Incidence of post-COVID syndrome and associated symptoms in outpatient care in Bavaria, Germany: a retrospective cohort study using routinely collected claims data. BMJ Open. 2022;12(9):e064979.
  • Jacob L, Koyanagi A, Smith L, et al. No significant association between COVID-19 diagnosis and the incidence of depression and anxiety disorder? A retrospective cohort study conducted in Germany. J Psychiatr Res. 2022;147:79–84.
  • Kompaniyets L, Bull-Otterson L, Boehmer TK, et al. Post-COVID-19 symptoms and conditions Among children and adolescents - United States, march 1, 2020-January 31, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(31):993–999.
  • Park HY, Song I-A, Lee SH, et al. Prevalence of mental illness among COVID-19 survivors in South Korea: nationwide cohort. BJPsych Open. 2021;7(6):e183.
  • Pietropaolo M, Hotez P, Giannoukakis N. Incidence of an insulin-requiring hyperglycemic syndrome in SARS CoV-2-infected young individuals: Is it type 1 diabetes? Diabetes. 2022;71(12):2656–2663.
  • Qureshi AI, Baskett WI, Huang W, et al. New-Onset dementia among survivors of pneumonia associated with severe acute respiratory syndrome coronavirus 2 infection. Open Forum Infect Dis. 2022;9(4):ofac115.
  • Rao S, Lee GM, Razzaghi H, et al. Clinical features and burden of postacute sequelae of SARS-CoV-2 infection in children and adolescents. JAMA Pediatr. 2022;176(10):1000–1009.
  • Rezel-Potts E, Douiri A, Sun X, et al. Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK. PLoS Med 2022;19(7):e1004052.
  • Roessler M, Tesch F, Batram M, et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: a matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022;19(11):e1004122.
  • Taquet M, Sillett R, Zhu L, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9(10):815–827.
  • Taquet M, Luciano S, Geddes JR, et al. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130–140.
  • Wang L, Davis PB, Volkow ND, et al. Association of COVID-19 with New-onset Alzheimer's disease. Journal of Alzheimer's Disease: Jad. 2022;89(2):411–414.
  • Wang W, Wang C-Y, Wang S-I, et al. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine. 2022;53:101619.
  • Westman G, Zelano J. Epilepsy diagnosis after COVID-19: A population-wide study. Seizure. 2022;101:11–14.
  • Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311–321.
  • Xie Y, Xu E, Bowe B, et al. Long-term cardiovascular outcomes of COVID-19. Nat Med 2022;28(3):583–590.
  • Xu E, Xie Y, Al-Aly  Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28:2406–2415.
  • Zarifkar P, Peinkhofer C, Benros ME, et al. Frequency of neurological diseases after COVID-19, influenza A/B and bacterial pneumonia. Front Neurol. 2022;13:904796.
  • Rader B, Gertz A, Iuliano AD, et al. Use of At-home COVID-19 tests - United States, August 23, 2021-march 12, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(13):489–494.